SENORES PHARMACEUTICALS L (SENORES) — Cash Flow Reinvestment Rate

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow Reinvestment Rate of 3.99x as of September 2025, reinvesting Rs966.90 Million (capex Rs966.90 Million ) from operating cash flow of Rs242.20 Million. Explore SENORES capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

3.99x
(Capex + Investments) / Operating CF

Total Reinvested

Rs966.90 Million
Capex + Investments

Operating Cash Flow

Rs242.20 Million
INR

Capital Expenditures

Rs966.90 Million
INR

Annual Cash Flow Reinvestment Rate for SENORES PHARMACEUTICALS L (None–None)

Year-by-year capital reinvestment analysis for SENORES PHARMACEUTICALS L. For live market cap and broader valuation context, see SENORES PHARMACEUTICALS L market cap and net worth.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow